Relmada Therapeutics (RLMD): CA and CO bought ~$103K

~$103K

Approx. value · 229K sh @ $0.4513

268K

Holds after · shares reported

Traded

May 16, 2025

Filed

May 20, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. May 16, 2025 · this disclosureInsiderOfficer purchased ~$103K of RLMD shares in the open market

What came next

1. May 16, 2025Insider · 3 peopleInsiders: 3 purchases (~$186K)
2. May 19, 2025Insider · 2 peopleInsiders: 2 purchases (~$59K)
3. May 20, 2025Insider · 2 peopleInsiders: 2 purchases (~$114K)
4. Aug 26, 2025InsiderCEO purchased ~$50K of RLMD shares in the open market
5. Aug 27, 2025InsiderCEO purchased ~$87K of RLMD shares in the open market
6. Aug 28, 2025InsiderCEO purchased ~$41K of RLMD shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Relmada Therapeutics

OQRO holds no insider, Congress, fund or contract record for Relmada Therapeutics dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its RLMD page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Relmada Therapeutics

• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRMay 15, 2026
• SEC Form 13F-HRFeb 17, 2026
• SEC Form 4Aug 28, 2025
• SEC Form 4Aug 28, 2025
• SEC Form 4Aug 28, 2025

Everything OQRO holds on this company is on its RLMD page.